Volume 10, Number 6—June 2004
Dispatch
Antibacterial Resistance, Wayampis Amerindians, French Guyana
Karine Grenet*, Didier Guillemot†, Vincent Jarlier‡, Brigitte Moreau§, Stéphane Dubourdieu*, Raymond Ruimy*, Laurence Armand-Lefevre*, Pierre Bau*, and Antoine Andremont*
Table 1
Antibacterial exposure in 388 Wayampi American Indians from three villages in southern French Guyana during the year preceding the studya
| Antibacterial agents | Frequency of antibacterial exposure in (%) |
||||
|---|---|---|---|---|---|
| TS (n = 85) | YP (n = 55) | Z (n = 248) | Total (n = 388) | p valueb | |
| Aminopenicillins |
5.9 |
14.6 |
23.8 |
18.6 |
0.007 |
| Metronidazole |
16.5 |
30.9 |
32.3 |
28.6 |
0.15 |
| Macrolides |
8.2 |
1.8 |
11.3 |
9.3 |
0.2 |
| Other |
5.8 |
7.3 |
8.9 |
8.0 |
0.7 |
| Overall | 36.5 | 54.6 | 76.2 | 64.4 | 0.007 |
aFrequency of antibacterial exposure was calculated by dividing the number of all antibacterial courses during the year preceding the study by the number of persons in each village.
bAnalysis of variance (ANOVA).
